The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies.
A MeierM de LaatD ReicheD FitzgeraldMartin N SillencePublished in: BMC veterinary research (2019)
Velagliflozin appears to be a promising and safe treatment for equine insulin dysregulation, bringing post-prandial insulin concentrations below the laminitis risk threshold, albeit without normalising them.